Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;113:38-43
Published online before print December 27, 2005, doi: 10.1161/CIRCULATIONAHA.105.575241
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
113/1/38    most recent
CIRCULATIONAHA.105.575241v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khera, A.
Right arrow Articles by McGuire, D. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khera, A.
Right arrow Articles by McGuire, D. K.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Coronary Artery Disease
Related Collections
Right arrow Risk Factors
Right arrow Imaging
Right arrow Epidemiology

(Circulation. 2006;113:38-43.)
© 2006 American Heart Association, Inc.


Epidemiology

Relationship Between C-Reactive Protein and Subclinical Atherosclerosis

The Dallas Heart Study

Amit Khera, MD, MSc; James A. de Lemos, MD; Ronald M. Peshock, MD; Hao S. Lo, BS; Harold G. Stanek, MS; Sabina A. Murphy, MPH; Frank H. Wians, Jr, PhD; Scott M. Grundy, MD, PhD; Darren K. McGuire, MD, MHSc

From the Donald W. Reynolds Cardiovascular Clinical Research Center (A.K., J.A.d.L., R.M.P., H.S.L., H.G.S., S.M.G., D.K.M.), Division of Cardiology (A.K., J.A.d.L., R.M.P., D.K.M.), Department of Pathology (F.H.W.), and Center for Human Nutrition (S.M.G.), University of Texas Southwestern Medical Center, Dallas, and Brigham and Women’s Hospital (S.A.M.), Boston, Mass.

Correspondence to Amit Khera, MD, MSc, Division of Cardiology, UT Southwestern Medical Center, 5909 Harry Hines Blvd, Room HA9.133, Dallas, TX 75390–9047. E-mail amit.khera{at}utsouthwestern.edu

Received February 17, 2005; de novo received July 11, 2005; revision received October 6, 2005; accepted October 14, 2005.

Background— Elevated levels of C-reactive protein (CRP) are associated with increased risk for incident cardiovascular events on the basis of observations from several prospective epidemiological studies. However, less is known regarding the relationship between CRP levels and atherosclerotic burden.

Methods and Results— We measured CRP in 3373 subjects 30 to 65 years of age who were participating in the Dallas Heart Study, a multiethnic, population-based, probability sample. Electron-beam CT scans were used to measure coronary artery calcification (CAC) in 2726 of these subjects, and MRI was used to measure aortic plaque in 2393. CRP levels were associated with most traditional cardiovascular risk factors. Subjects with CAC had higher median CRP levels than those without CAC (men: median, 2.4 versus 1.8 mg/L, P<0.001; women: median, 5.2 versus 3.6 mg/L, P<0.001), and there was a modest trend toward increasing CRP levels with increased CAC levels in men (P for trend=0.003) but not in women (P for trend=0.08). Male subjects with aortic plaque also had higher CRP levels than those without (median, 2.3 versus 1.8; P<0.001). In multivariate analysis adjusted for traditional cardiovascular risk factors, body mass index, and estrogen and statin medication use, the associations between CRP levels and CAC and CRP levels and aortic plaque were no longer statistically significant.

Conclusions— In a large, population-based sample, subjects with higher CRP levels had a modest increase in the prevalence of subclinical atherosclerosis, but this association was not independent of traditional cardiovascular risk factors. CRP is a poor predictor of atherosclerotic burden.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Wu, M. J. Stevenson, J. M. Brown, E. A. Grunz, T. L. Strawn, and W. P. Fay
C-Reactive Protein Enhances Tissue Factor Expression by Vascular Smooth Muscle Cells: Mechanisms and In Vivo Significance
Arterioscler. Thromb. Vasc. Biol., April 1, 2008; 28(4): 698 - 704.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D Conen, B M Everett, R J Glynn, and P M Ridker
Effect of valsartan compared with valsartan/hydrochlorothiazide on plasma levels of cellular adhesion molecules: the Val-MARC trial
Heart, March 1, 2008; 94(3): e13 - e13.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. K. McGuire and S. E. Inzucchi
New Drugs for the Treatment of Diabetes Mellitus: Part I: Thiazolidinediones and Their Evolving Cardiovascular Implications
Circulation, January 22, 2008; 117(3): 440 - 449.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. M. Novaro, R. Katz, R. J. Aviles, J. S. Gottdiener, M. Cushman, B. M. Psaty, C. M. Otto, and B. P. Griffin
Clinical Factors, But Not C-Reactive Protein, Predict Progression of Calcific Aortic-Valve Disease: The Cardiovascular Health Study
J. Am. Coll. Cardiol., November 13, 2007; 50(20): 1992 - 1998.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. H. Stone
C-Reactive Protein to Identify Early Risk for Development of Calcific Aortic Stenosis: Right Marker? Wrong Time?
J. Am. Coll. Cardiol., November 13, 2007; 50(20): 1999 - 2001.
[Full Text] [PDF]


Home page
Ann Rheum DisHome page
L. Carmona, M. A. Descalzo, E. Perez-Pampin, D. Ruiz-Montesinos, A. Erra, T. Cobo, J. J Gomez-Reino, and on behalf of the BIOBADASER and EMECAR Groups
All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists
Ann Rheum Dis, July 1, 2007; 66(7): 880 - 885.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Omland, M. H. Drazner, T. Ueland, M. Abedin, S. A. Murphy, P. Aukrust, and J. A. de Lemos
Plasma Osteoprotegerin Levels in the General Population: Relation to Indices of Left Ventricular Structure and Function
Hypertension, June 1, 2007; 49(6): 1392 - 1398.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
O. Ben-Yehuda
High-Sensitivity C-Reactive Protein in Every Chart?: The Use of Biomarkers in Individual Patients
J. Am. Coll. Cardiol., May 29, 2007; 49(21): 2139 - 2141.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Sanz, P. R. Moreno, and V. Fuster
The Year in Atherothrombosis
J. Am. Coll. Cardiol., April 24, 2007; 49(16): 1740 - 1749.
[Full Text] [PDF]


Home page
DiabetesHome page
T. Mazzone, P. M. Meyer, G. T. Kondos, M. H. Davidson, S. B. Feinstein, R. B. D'Agostino Sr., A. Perez, and S. M. Haffner
Relationship of Traditional and Nontraditional Cardiovascular Risk Factors to Coronary Artery Calcium in Type 2 Diabetes
Diabetes, March 1, 2007; 56(3): 849 - 855.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
G. M. Felker, J. W. Petersen, and D. B. Mark
Natriuretic peptides in the diagnosis and management of heart failure.
Can. Med. Assoc. J., September 12, 2006; 175(6): 611 - 617.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Zalewski, J. J. Nelson, L. Hegg, and C. Macphee
Lp-PLA2: A New Kid on the Block
Clin. Chem., September 1, 2006; 52(9): 1645 - 1650.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Juonala, J. S.A. Viikari, T. Ronnemaa, L. Taittonen, J. Marniemi, and O. T. Raitakari
Childhood C-Reactive Protein in Predicting CRP and Carotid Intima-Media Thickness in Adulthood: The Cardiovascular Risk in Young Finns Study
Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1883 - 1888.
[Abstract] [Full Text] [PDF]